Nyxoah SA EBITDA 2021-2024 | NYXH
Nyxoah SA ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Nyxoah SA Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-46 |
| 2022 | $-32 |
| 2021 | $-29 |
| 2020 | $-12 |
| Nyxoah SA Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-16 |
| 2024-06-30 | $-14 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-11 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-12 |
| 2023-03-31 | $-12 |
| 2022-12-31 | $-9 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-7 |
| 2022-03-31 | $-8 |
| 2021-12-31 | |
| 2021-03-31 | $-6 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||